Nucleic acid ligands to integrins
US7094535B2 · kind B2 · utility
3Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2001 |
| Grant date | Aug 22, 2006 |
| Priority date | — |
| Expiry date | May 5, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/322
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Methods are described for the isolation of nucleic acid ligands to integrins using the SELEX process. SELEX is an acronym for Systematic Evolution of Ligands by EXponential enrichment. The nucleic acid ligands of the present invention are useful as therapeutic and diagnostic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.